Dextenza intraocular and Disopyramide Sustained-Release Capsules
Determining the interaction of Dextenza intraocular and Disopyramide Sustained-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexamethasone ophthalmic
Brand name: Dextenza, Dexycu, Ozurdex, Maxidex
Synonyms: Dextenza (intraocular), Dextenza Insert
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dextenza intraocular-DisperMox
- Dextenza intraocular-Disposable Enema rectal
- Dextenza intraocular-Disulfiram
- Dextenza intraocular-Dithol Solution
- Dextenza intraocular-Ditropan
- Dextenza intraocular-Ditropan XL
- Disopyramide Sustained-Release Capsules-Dextran 40
- Disopyramide Sustained-Release Capsules-Dextran 70 6% in 5% Dextrose high molecular weight
- Disopyramide Sustained-Release Capsules-Dextran 75
- Disopyramide Sustained-Release Capsules-Dextran high molecular weight
- Disopyramide Sustained-Release Capsules-Dextranomer and Hyaluronate Derivatives (Deflux)
- Disopyramide Sustained-Release Capsules-Dextranomer and Hyaluronate Derivatives (Solesta)